Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2013
11/21/2013US20130310379 Modulators of methyl modifying enzymes, compositions and uses thereof
11/21/2013US20130310344 N-acylsulfonamide apoptosis promoters
11/21/2013US20130310254 Alpha, beta-unsaturated imines
11/20/2013EP2480532B1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis
11/20/2013EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
11/20/2013EP2252149B1 A method for the preparation of fentanyl
11/20/2013EP1540037B1 Organic salts and their use as reagents in electrochemical reactions
11/20/2013CN203295401U Device for producing tetramethyl pipradrol by continuous catalytic hydrogenation
11/20/2013CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa
11/20/2013CN103396329A Method for preparing beta-perfluoroalkyl enaminoketone
11/20/2013CN102718698B Aspartic acid amlodipine compound and synthesis method thereof
11/19/2013US8586755 Substituted nicotinamides as KCNQ2/3 modulators
11/19/2013US8586750 Method for the production of halogen-substituted 2-(aminomethylidene)-3-oxobutyric acid esters
11/19/2013US8586749 Compounds that suppress cancer cells and exhibit antitumor activity
11/19/2013US8586743 Labeling reagents and methods of their use
11/19/2013US8586575 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
11/19/2013US8586571 Heterocyclic compound
11/19/2013CA2633624C 3,5-substituted piperidine compounds as renin inhibitors
11/19/2013CA2603030C Benzyloxypropylamine derivative
11/14/2013WO2013168024A1 Prodrugs of anti-platelet agents
11/14/2013WO2013168022A1 Compositions and methods for treating atherothrombosis
11/14/2013WO2013168019A1 Compositions and methods for the treatment of neuropathic pain
11/14/2013WO2013131010A3 Function of chemokine receptor ccr8 in melanoma metastasis
11/14/2013US20130303771 Process for preparing cyclic amine compounds
11/14/2013US20130303757 Polymer precursors of radiolabeled compounds, and methods of making and using the same
11/14/2013US20130303568 Substituted 2-Aminoacetamides and the Use Thereof
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013CA2873138A1 Compositions and methods for the treatment of local pain
11/14/2013CA2873087A1 Compositions and methods for the treatment of hyperglycemia
11/13/2013EP2662353A2 Antibacterial agents
11/13/2013EP2569263B1 A thionation process and a thionating agent
11/13/2013CN103387567A NEPT compound and preparation method and application thereof
11/13/2013CN103387533A Method for synthesis of chiral piperidine derivative through iridium-catalyzed asymmetric hydrogenation of pyridine
11/13/2013CN102603615B Intermediates of 2-acetonyl-3-methoxy piperidine and preparation method of 2-acetonyl-3-methoxy piperidine
11/13/2013CN102442937B Method for preparing 1-benzyl-4-aniline piperidine-4-carboxylic acid
11/13/2013CN102137889B Stabilisers for inanimate organic materials
11/13/2013CN101974026B Allyl acyl silicon compound with two chiral centers in positions alpha and beta, preparation method and application
11/12/2013US8580965 Substituted sulfonamide compounds
11/12/2013US8580822 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
11/12/2013US8580821 Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
11/12/2013CA2537093C Compound capable of binding s1p receptor and pharmaceutical use thereof
11/07/2013US20130296569 Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
11/07/2013US20130296323 Gga and gga derivatives compositions thereof and methods for treating neurodegenerative diseases including paralysis including them
11/07/2013US20130296283 Polymorphs of donepezil salts, preparation methods and uses thereof
11/07/2013US20130296245 Prolinamiade derivatives as thrombin inhibitor, prepraration method and application thereof
11/06/2013CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments
11/06/2013CN103382175A Preparation method for cleviprex crystal form II
11/06/2013CN102378739B Method for preparing cha-type molecular sieves using novel structure directing agents
11/06/2013CN101679399B Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/05/2013US8575352 Benzyl sulfonamide derivatives useful as MOGAT-2 inhibitors
11/05/2013US8575350 Process for producing pyridine carboxylic acids
11/05/2013US8575196 Oligomer-opioid agonist conjugates
11/05/2013US8574633 Huperzia serrata (Thunb.) Trev. composition comprising compounded Huperzine A and Huperzine B and methods for preparing it
11/05/2013US8574569 Stabilized protease composition
11/05/2013CA2491994C Modulators of the glucocorticoid receptor
10/2013
10/31/2013WO2013163454A2 Psyllid attractants and their uses
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161851A1 Benzamide derivative
10/31/2013WO2013160389A1 Method for preparing lactams
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/31/2013US20130289270 Amination of Aryl Alcohol Derivatives
10/31/2013US20130289073 Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
10/31/2013US20130289034 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
10/31/2013US20130289003 Diazeniumdiolate heterocyclic derivatives
10/31/2013US20130287727 Psyllid Attractants and Their Uses
10/30/2013EP2657234A1 Optically-active diazabicyclooctane derivative and method for manufacturing same
10/30/2013EP2657225A2 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
10/30/2013EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/30/2013CN103380113A Amine-containing transfection reagents and methods for making and using same
10/30/2013CN103373956A Method for preparing clevidipine butyrate
10/30/2013CN103373955A Multivalent azasugar derivatives and synthetic method thereof
10/30/2013CN103373954A Preparation method of1-benzyl-4-methoxymethyl-4-aniline piperidine hydrochloride
10/30/2013CN103373953A Preparation method for 3-aminopiperidine and optical isomer thereof
10/30/2013CN102351784B Benidipine hydrochloride crystal form and application thereof
10/30/2013CN102153504B Method for preparing 1-deoxynojirimycin in mulberry leaves
10/30/2013CN102127006B Production method of donepezil hydrochloride
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/29/2013US8569343 Oligomer-opioid agonist conjugates
10/29/2013US8569342 Diastereomers of 4-aryloxy-3-hydroxypiperidines
10/29/2013US8569341 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
10/29/2013US8569289 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
10/29/2013US8568756 Inhibition of quorum sensing-mediated processes in bacteria
10/24/2013US20130281702 Methods For Preparing Fentanyl And Fentanyl Intermediates
10/24/2013US20130281294 Use of sarmentine and its analogs for controlling plant pests
10/23/2013EP2651892A1 Low-temperature synthesis of methylphenidate hydrochloride
10/23/2013EP2651891A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
10/23/2013CN103360302A Purification method of alvimopa
10/23/2013CN103360301A Purifying method for alvimopan intermediate
10/23/2013CN103360300A Synthesis method of alvimopan
10/22/2013US8563734 2-[1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
10/22/2013US8563732 Oxyimino compounds and the use thereof
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563582 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/22/2013US8563544 2,5-disubstituted arylsulfonamide CCR3 antagonists
10/22/2013CA2528179C Piperidinyl prostaglandin e analogs
10/17/2013WO2013155223A1 Compositions and methods for treating cancer
10/17/2013US20130274476 Conformationally restricted urea inhibitors of soluble epoxide hydrolase
10/17/2013US20130274475 Beta-lactamase inhibitors
10/17/2013US20130274240 Fluorene compound and pharmaceutical use thereof
10/16/2013EP2650281A1 Process for preparing cyclic amine compounds
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 380